In yesterday’s Wall Street session, Coeptis Therapeutics Holdings Inc (NASDAQ:COEP) shares traded at $0.18, down -13.65% from the previous session.
COEP stock price is now -6.75% away from the 50-day moving average and -27.52% away from the 200-day moving average. The market capitalization of the company currently stands at $6.47M.
In other news, Cogley Brian, Chief Financial Officer bought 5,000 shares of the company’s stock on Jan 10 ’24. The stock was bought for $3,350 at an average price of $0.67. Upon completion of the transaction, the Chief Financial Officer now directly owns 30,000 shares in the company, valued at $5400.0. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 12 ’24, Director DeSilva Tara bought 2,266 shares of the business’s stock. A total of $1,305 was incurred on buying the stock at an average price of $0.58. This leaves the insider owning 32,266 shares of the company worth $5807.88. A total of 28.08% of the company’s stock is owned by insiders.
During the past 12 months, Coeptis Therapeutics Holdings Inc has had a low of $0.13 and a high of $0.82. As of last week, the company has a debt-to-equity ratio of 0.26, a current ratio of 0.40, and a quick ratio of 0.40. The fifty day moving average price for COEP is $0.19552 and a two-hundred day moving average price translates $0.25145 for the stock.
The latest earnings results from Coeptis Therapeutics Holdings Inc (NASDAQ: COEP) was released for 2024-06-30. The company reported revenue of $2.14 million for the quarter, compared to $7.9 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -72.89 percent.
